Clinical Trial 42502

Upland, CA 91786


A phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluationgthe efficacy and safety of bimekizumab in subjects with active Nonradiographic Axial Spondyloarthritis.

Qualified Participants Must:

• Subject is male or female at least 18 years of age
• Inflamatory back pain for at least 3 months prior to screening visit
• Age at symptoms onset prior to age 45
• Inadequate response to NSAID therapy or intolerance to administration of at least 1 NSAID
• Subjects must have active disease as defined by both of the following visits screening and baseline.

Qualified Participants May Receive:

Free study medication if qualify and enrolled into the study. Free doctor visits along with blood results. Once you are qualified and enrolled into study you will receive $40.00 per visit completed.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.